Panther Biotechnology is focused on the acquisition and development of small molecule therapeutics for the treatment of Leukemia, Lymphoma and Myeloma.


Panther Biotechnology, Inc. Announces Record Date for Biotechnology Milestone Earn-Out Consideration Shares in Response to Recent Positive Feedback from the FDA December 16, 2016

Panther Biotechnology Receives Positive Feedback from the FDA December 7, 2016

Panther Biotechnology Announces Meeting With U.S. Food and Drug Administration October 24, 2016

Panther Biotechnology Requests Pre-IND Meeting With FDA October 14, 2016

Panther Biotechnology Announces Entry Into Letter of Intent to Acquire Brown Technical Media Corp. September 22, 2016

Panther Biotechnology Announces the Initiation of Formal Development of Transferrin Doxorubicin Conjugate July 14, 2016

Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners August 25, 2015

Panther Biotechnology Announces the Closing of the Acquisition of Technology Assets of Faulk Pharmaceuticals July 16, 2015

Panther Biotechnology Announces the Acquisition of Alchemia Oncology Pty Limited July 1, 2015

Panther Biotechnology Reports the Fiscal Year Ended May 2014 and the First Three Quarters of Fiscal Year 2015 Bringing the Company Current in Its SEC Filing Obligations

Panther Chairman to Step Down for Health Reasons June 1, 2015

Panther Biotechnology Announces New Drug Candidate to Selectively Kill Leukemia Stem Cells April 17, 2015

Panther Biotechnology Announces Agreement to Acquire Technology Assets of Faulk Pharmaceuticals April 7, 2015

Panther Biotechnology Announces Exclusive License Agreement with Northwestern University April 1, 2015

Panther Biotechnology Announces New Chief Executive Officer March 23, 2015

Renowned USC/Norris Cancer Researcher, Dr. Heinz-Josef Lenz, Joins Panther Biotechnology Board of Directors September 11, 2014

Panther Biotechnology, Inc. Announces the Appointment of Two Directors and Securing an Option on a Potential Blockbuster Novel Oncology Small Molecule With Northwestern University That Panther Will Fast Track Into the Clinic August 26, 2014 

Panther Biotechnology will be presenting at the International Cancer Cluster Showcase June 22, 2014